The "pro-drug" RibCys decreases the mutagenicity of high-LET radiation in cultured mammalian cells. [electronic resource]
Producer: 20040108Description: 579-83 p. digitalISSN:- 0033-7587
- Animals
- CHO Cells
- Carbon Radioisotopes
- Cell Count
- Cell Survival -- drug effects
- Cricetinae
- Cricetulus
- Cysteine -- analogs & derivatives
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Humans
- Hybrid Cells -- cytology
- Iron Radioisotopes
- Linear Energy Transfer
- Lymphocytes -- cytology
- Mutation -- drug effects
- Prodrugs -- pharmacology
- Radiation Dosage
- Radiation Tolerance -- drug effects
- Radiation-Protective Agents -- pharmacology
- Thiazoles -- pharmacology
- Thiazolidines
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.